TFRC and glioma: Inspired by these results, we used T7 and dA7R peptides in this work to enhance the HDL (abbreviated as T7/dA7R-HDL) to overcome the multiple physiological barriers (BBB and BBTB) and actively target glioma cells via interacting with the TfR and VEGFR 2.